Description
IXAZOMIB MAINTENANCE SIGNIFICANTLY DELAYS DISEASE PROGRESSION FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA
€3.03
IXAZOMIB MAINTENANCE SIGNIFICANTLY DELAYS DISEASE PROGRESSION FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA
You must be logged in to post a review.
Reviews
There are no reviews yet.